NRX Pharmaceuticals (NRXP) Operating Income Growth (3y) (2020 - 2026)
NRX Pharmaceuticals (NRXP) Operating Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | NRX Pharmaceuticals | 119.60 Mn | 112.90 Mn | 437,000.00 | -7.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.22% |
| Dec 31, 2025 | 22.38% |
| Sep 30, 2025 | 23.93% |
| Jun 30, 2025 | 27.03% |
| Mar 31, 2025 | 37.43% |
| Dec 31, 2024 | 64.19% |
| Sep 30, 2024 | 46.83% |
| Jun 30, 2024 | 25.60% |
| Mar 31, 2024 | 38.36% |
| Dec 31, 2023 | 53.95% |
| Sep 30, 2023 | -4.09% |
| Jun 30, 2023 | -331.09% |
| Mar 31, 2023 | -218.29% |
| Dec 31, 2022 | -272.73% |
| Sep 30, 2022 | -268.08% |
| Jun 30, 2022 | -279.43% |
| Mar 31, 2022 | -358.27% |
| Sep 30, 2021 | -208.52% |
| Jun 30, 2021 | -232.85% |
| Mar 31, 2021 | -410.57% |